A prospective study of oral 5-aminolevulinic acid to prevent adverse events in patients with localized prostate cancer undergoing low-dose-rate brachytherapy: Protocol of the AMBER study

BACKGROUND: Radiotherapy is one of the most frequently selected treatment options for patients with prostate cancer. However, adverse effects related to the irradiated surrounding normal organs are significant clinical concerns. Specifically, genitourinary and gastrointestinal toxicities can lead to...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyake, Makito, Tanaka, Nobumichi, Asakawa, Isao, Yamaki, Kaori, Inoue, Takashi, Suzuki, Shota, Hori, Shunta, Nakai, Yasushi, Anai, Satoshi, Torimoto, Kazumasa, Toritsuka, Michihiro, Nakagawa, Hitoshi, Tsukamoto, Shinji, Fujii, Tomomi, Ohbayashi, Chiho, Hasegawa, Masatoshi, Kasahara, Masato, Fujimoto, Kiyohide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327239/
https://www.ncbi.nlm.nih.gov/pubmed/32637724
http://dx.doi.org/10.1016/j.conctc.2020.100593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327239/
https://www.ncbi.nlm.nih.gov/pubmed/32637724
http://dx.doi.org/10.1016/j.conctc.2020.100593

Ejemplares similares